Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Neuroprotective agents for cerebral malaria
FY 2015-16
Summary
Malaria is the leading cause of parasitic deaths worldwide, accounting for an estimated 1.24 million deaths annually. Although malaria there are prevention methods and treatments available, approximately 3.2 billion people remain at risk of becoming infected, particularly young children and pregnant women. These populations are especially susceptible to the most severe form of malaria, cerebral malaria, which can cause dysfunction of the blood-brain barrier and subsequent long-term neurocognitive disability. Using test tube and experimental models, we will study the ability of neuroprotective agents to prevent these outcomes. Our studies will accelerate the development of new anti-malarial therapies and reduce the negative health impact of malaria.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
349918
Name
Brooks Hannah M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Neuroprotective agents for cerebral malaria
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood Brain Barrier; Cerebral Malaria; Cognitive Dysfunction; Infectious Diseases; Malaria; Neuroprotection; Parasites
Abstract
Malaria is the leading cause of parasitic deaths worldwide, accounting for an estimated 1.24 million deaths annually. Although malaria there are prevention methods and treatments available, approximately 3.2 billion people remain at risk of becoming infected, particularly young children and pregnant women. These populations are especially susceptible to the most severe form of malaria, cerebral malaria, which can cause dysfunction of the blood-brain barrier and subsequent long-term neurocognitive disability. Using test tube and experimental models, we will study the ability of neuroprotective agents to prevent these outcomes. Our studies will accelerate the development of new anti-malarial therapies and reduce the negative health impact of malaria.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brooks, Hannah M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~